MYUNGMOON Pharm co.,Ltd Statistics

Total Valuation

MYUNGMOON Pharm co.,Ltd has a market cap or net worth of KRW 64.41 billion. The enterprise value is 150.75 billion.

Market Cap	64.41B
Enterprise Value	150.75B

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

MYUNGMOON Pharm co.,Ltd has 33.53 million shares outstanding. The number of shares has decreased by -2.20% in one year.

Current Share Class	n/a
Shares Outstanding	33.53M
Shares Change (YoY)	-2.20%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	21.31%
Owned by Institutions (%)	0.33%
Float	26.38M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.36
PB Ratio	0.80
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-19.53
EV / Sales	0.85
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-39.48

Financial Position

The company has a current ratio of 0.93, with a Debt / Equity ratio of 1.09.

Current Ratio	0.93
Quick Ratio	0.58
Debt / Equity	1.09
Debt / EBITDA	661.00
Debt / FCF	-24.39
Interest Coverage	-0.76

Financial Efficiency

Return on equity (ROE) is -9.09% and return on invested capital (ROIC) is -1.38%.

Return on Equity (ROE)	-9.09%
Return on Assets (ROA)	-1.05%
Return on Capital (ROIC)	-1.38%
Revenue Per Employee	627.64M
Profits Per Employee	-27.47M
Employee Count	281
Asset Turnover	0.74
Inventory Turnover	2.48

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -17.91% in the last 52 weeks. The beta is 0.18, so MYUNGMOON Pharm co.,Ltd's price volatility has been lower than the market average.

Beta (5Y)	0.18
52-Week Price Change	-17.91%
50-Day Moving Average	2,164.08
200-Day Moving Average	2,159.04
Relative Strength Index (RSI)	35.29
Average Volume (20 Days)	557,643

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MYUNGMOON Pharm co.,Ltd had revenue of KRW 176.37 billion and -7.72 billion in losses. Loss per share was -231.81.

Revenue	176.37B
Gross Profit	97.99B
Operating Income	-4.00B
Pretax Income	-9.23B
Net Income	-7.72B
EBITDA	140.90M
EBIT	-4.00B
Loss Per Share	-231.81

Full Income Statement

Balance Sheet

The company has 11.77 billion in cash and 93.13 billion in debt, giving a net cash position of -81.37 billion or -2,426.87 per share.

Cash & Cash Equivalents	11.77B
Total Debt	93.13B
Net Cash	-81.37B
Net Cash Per Share	-2,426.87
Equity (Book Value)	85.65B
Book Value Per Share	2,406.24
Working Capital	-6.29B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -2.71 billion and capital expenditures -1.11 billion, giving a free cash flow of -3.82 billion.

Operating Cash Flow	-2.71B
Capital Expenditures	-1.11B
Free Cash Flow	-3.82B
FCF Per Share	-113.90

Full Cash Flow Statement

Margins

Gross margin is 55.56%, with operating and profit margins of -2.27% and -4.38%.

Gross Margin	55.56%
Operating Margin	-2.27%
Pretax Margin	-5.23%
Profit Margin	-4.38%
EBITDA Margin	0.08%
EBIT Margin	-2.27%
FCF Margin	-2.17%

Dividends & Yields

MYUNGMOON Pharm co.,Ltd does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.20%
Shareholder Yield	2.20%
Earnings Yield	-12.07%
FCF Yield	-5.93%

Stock Splits

The last stock split was on January 3, 2018. It was a forward split with a ratio of 1.0209290454.

Last Split Date	Jan 3, 2018
Split Type	Forward
Split Ratio	1.0209290454

Scores

MYUNGMOON Pharm co.,Ltd has an Altman Z-Score of 0.96. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.96
Piotroski F-Score	n/a